Irofulven

WikiDoc Resources for Irofulven
Articles
Most recent articles on Irofulven Most cited articles on Irofulven Review articles on Irofulven Articles on Irofulven in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Irofulven Images of Irofulven Photos of Irofulven Podcasts & MP3s on Irofulven Videos on Irofulven
Evidence Based Medicine
Cochrane Collaboration on Irofulven Bandolier on Irofulven TRIP on Irofulven
Clinical Trials
Ongoing Trials on Irofulven at Clinical Trials.gov Trial results on Irofulven Clinical Trials on Irofulven at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Irofulven NICE Guidance on Irofulven NHS PRODIGY Guidance FDA on Irofulven CDC on Irofulven
Books
Books on Irofulven
News
Irofulven in the news Be alerted to news on Irofulven News trends on Irofulven
Commentary
Blogs on Irofulven
Definitions
Definitions of Irofulven
Patient Resources / Community
Patient resources on Irofulven Discussion groups on Irofulven Patient Handouts on Irofulven Directions to Hospitals Treating Irofulven Risk calculators and risk factors for Irofulven
Healthcare Provider Resources
Symptoms of Irofulven Causes & Risk Factors for Irofulven Diagnostic studies for Irofulven Treatment of Irofulven
Continuing Medical Education (CME)
CME Programs on Irofulven
International
Irofulven en Espanol Irofulven en Francais
Business
Irofulven in the Marketplace Patents on Irofulven
Experimental / Informatics
List of terms related to Irofulven

Overview

Irofulven or 6-hydroxymethylacylfulvene (also known as HMAF of MGI-114) is a substance that is used in the treatment of cancer. It belongs to the family of drugs called alkylating agents.

Irofulven is an analogue of illudin S, a sesquiterpene toxin found in mushrooms of the genus Omphalotus. The compound was oringally synthesized by Dr. Trevor McMorris (UCSD) and found to have anticancer properties by Dr. Michael J Kelner (UCSD).

References

Kelner MJ, McMorris TC, Estes L, Wang W, Samson KM, Taetle R. Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents. Invest New Drugs 14(2) 161-167, 1996 Template:WH Template:WikiDoc Sources